DNA Sequencing Electrophoresis System Market 2028 By Product, Application, End-User | The Insight Partners

report image

DNA Sequencing Electrophoresis System Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Consumable, Instrument); Application (Research, Diagnostics, Quality Control and Process Validation); End-User (Academic and Government Research Institutes, Hospitals and Diagnostics Centers, Biotechnology and Pharmaceutical Companies)

Report Code: TIPRE00008456 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming


The process of determining the sequence of nucleotide bases (As, Ts, Cs, and Gs) in a molecule of DNA is known as DNA sequencing. Electrophoresis is an electrokinetic method that uses an electrical charge field to separate charged particles in a fluid. It's most commonly employed in life sciences to separate protein molecules or DNA, and depending on the type and size of the molecules, it can be done in a variety of ways. Although the techniques differ in several areas, they always require an electrical charge source, a support medium, and a buffer solution. In laboratories, electrophoresis is used to separate molecules depending on their size, density, and purity.


The "Global DNA Sequencing Electrophoresis System Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the DNA sequencing electrophoresis system market with detailed market segmentation by product, application, end-user and geography. The report provides key statistics on the market status of the leading DNA sequencing electrophoresis system market players and offers key trends and opportunities in the market.


  •   On the basis of product, the market is segmented into instrument and consumable.
  •   Based on application, the market is bifurcated into research, diagnostics, and quality control and process validation.
  •   Based on end-user, the market is bifurcated into academic and government research institutes, hospitals and diagnostics centers, and biotechnology and pharmaceutical companies.


  •   Surge in applications of DNA sequencing.
  •   Rising prevalence of chronic diseases.
  •   increasing expenditure on research & development and advancement in technologies.


  •   DNA sequencing using electrophoresis methods, such as gel electrophoresis (which requires manual pouring of the gel), requires a significant amount of time to produce results and this method does not provide accurate results, hampering the growth of the market during the reporting period.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The DNA sequencing electrophoresis system market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the DNA sequencing electrophoresis system market in these regions.


COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities. DNA sequencing electrophoresis system market is moderately affected due to COVID-19.

Get more information on this report :


The report covers key developments in the DNA sequencing electrophoresis system market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from DNA sequencing electrophoresis system market are anticipated to lucrative growth opportunities in the future with the rising demand for DNA sequencing electrophoresis system in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the DNA sequencing electrophoresis system market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Biocompare
  •   Bio-Rad Laboratories, Inc.
  •   GE Healthcare
  •   Thermo Fisher Scientific Inc.
  •   Agilent Technologies, Inc.
  •   Perkinelmer, Inc.
  •   Qiagen N.V.
  •   Merck Millipore
  •   Lonza Group LTD
  •   Shimadzu Corporation
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Get more information on this report :

The List of Companies

1. Biocompare
2. Bio-Rad Laboratories, Inc.
3. GE Healthcare
4. Thermo Fisher Scientific Inc.
5. Agilent Technologies, Inc.
6. Perkinelmer, Inc.
7. Qiagen N.V.
8. Merck Millipore
9. Lonza Group LTD
10. Shimadzu Corporation
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount